Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Bloodstream Infection.

Author
Zasowski, Evan J
Trinh, Trang D
Claeys, Kimberly C
Lagnf, Abdalhamid M
Bhatia, Sahil
Klinker, Kenneth P
Veve, Michael P
Estrada, Sandy J
Johns, Scott T
Sawyer, Adam J
Date
2021-12-23
Journal
Open Forum Infectious Diseases
Publisher
Oxford University Press
Type
Article

Metadata
Show full item record
See at
https://doi.org/10.1093/ofid/ofab606
Abstract
Observational data suggest ceftaroline may be effective for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI), but comparative data with standard of care are limited. This analysis compares the outcomes of MRSA BSI treated with ceftaroline or daptomycin.
Rights/Terms
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Keyword
MRSA
bacteremia
infective endocarditis
lipoglycopeptide
β-lactam
Identifier to cite or link to this item
http://hdl.handle.net/10713/18008
Collections